About 6 months ago I lost my father to Glioblastoma Multiforme (GBM) not even 6 months after his diagnosis. Glioblastoma multiforme is the deadliest and most difficult to treat form of brain cancer with an average medial survial of 14 months. Each day 500 people will be diagnosed with a brain tumor and about 12,000 a year are diagnosed with glioblastoma multiforme. Glioblastomas are malignant, aggressive, and can be difficult to treat due to the multple cell types within the tumor that reproduce rapidly. Clinical trials are currently underway for different forms of immunotherapy, which are therapies that target ones own immue system to fight cancer cells and slow the progression of GBM.
For more than 40 years The American Brain Tumor Association (ABTA) has been funding research in the pursuit of breakthroughs in brain tumor diagnosis, treatment and care, as well as providing comprehensive resources to support brain tumor patients and caregivers.
To show my support, I will be running in the 2017 Chicago Marathon part of the ABTA's Team Breakthrough, charity partner to Bank of America. The money raised will provide will provide critical funding for brain tumor research and for supportive patient care.
You can support me in my efforts by making a donation to the American Brain Tumor Association.
Click on “Donate Now” to donate safely and securely.
Your donation not only supports brain tumor patients and their families, but it also supports the breakthrough research to improve, extend and ultimately save lives.
Your donation is tax-deductible. You can learn more about the American Brain Tumor Association at www.abta.org. Thank you for your support.